Inclisiran for Subjects With ASCVD or ASCVD-Risk Equivalents and Elevated Low-density Lipoprotein Cholesterol
Clinical trial NCT03400800 · COMPLETED
Trial details
- NCT number
- NCT03400800
- Sponsor
- The Medicines Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-01
- Primary completion
- 2019-07-31
- Enrollment
- 1617
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.